Home - Products - Others - Other Targets - Morpholinylmercaptobenzothiazole

Morpholinylmercaptobenzothiazole

CAS No. 102-77-2

Morpholinylmercaptobenzothiazole( —— )

Catalog No. M23231 CAS No. 102-77-2

Morpholinylmercaptobenzothiazole is an aftereffect rapid vulcanization accelerator.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 28 In Stock
5MG 45 In Stock
10MG 68 In Stock
25MG 115 In Stock
50MG 173 In Stock
100MG 258 In Stock
200MG 388 In Stock
500MG 642 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Morpholinylmercaptobenzothiazole
  • Note
    Research use only, not for human use.
  • Brief Description
    Morpholinylmercaptobenzothiazole is an aftereffect rapid vulcanization accelerator.
  • Description
    Morpholinylmercaptobenzothiazole is an aftereffect rapid vulcanization accelerator.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    102-77-2
  • Formula Weight
    252.4
  • Molecular Formula
    C11H12N2OS2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:10 mM
  • SMILES
    C1COCCN1SC2=NC3=CC=CC=C3S2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Basu D K . Amperometric determination of 2-benzothiazole sulphenamide accelerators[J]. Talanta, 1980, 27(8):671-672.
molnova catalog
related products
  • Levulinic acid

    Levulinic acid derived from the degradation of cellulose is a precursor for the synthesis of biofuels such as ethyl levulinate.

  • Oblongine

    Oblongine chloride may have potential haemodynamic effects, it can cause a dose-dependent reduction of systolic and diastolic blood pressure, and that these effects are not mediated by α2-adrenergic receptor stimulation.

  • Trofinetide

    Trofinetide (NNZ 2566 ) is a peptidomimetic tripeptide Gly-Pro-Glu that has anti-inflammatory and neuroprotective properties against hypoxic-ischemic brain injury and neurodegeneration.